BZYR Burzynski Research Institute, Inc. OTC · United States

Burzynski Research Institute (BZYR) news

Burzynski Research Institute, Inc. is a public biotech or pharmaceutical company listed on OTC under the ticker BZYR, recorded under United States. The directory classifies it as Biopharma / pharmaceutical profile checked. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Burzynski Research Institute news

We have not published a story on Burzynski Research Institute yet. When there is news, it will appear here.

Questions about Burzynski Research Institute

What is the ticker symbol of Burzynski Research Institute?

Burzynski Research Institute, Inc. trades under the ticker BZYR on OTC.

Where is Burzynski Research Institute listed?

Burzynski Research Institute, Inc. is listed on OTC.

Which country or territory is Burzynski Research Institute listed under?

Our directory records Burzynski Research Institute, Inc. under United States.

What does Burzynski Research Institute do?

Our directory classifies Burzynski Research Institute, Inc. as: Biopharma / pharmaceutical profile checked. This is a directory classification, not a description of the pipeline.

What is the ISIN of Burzynski Research Institute?

The ISIN recorded for Burzynski Research Institute, Inc. is US1231591058.

Does aibio.space cover Burzynski Research Institute?

aibio.space lists Burzynski Research Institute, Inc. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Burzynski Research Institute?

Companies in our directory listed in the same country and business area as Burzynski Research Institute: Scilex Holding, PharmaCyte Biotech, TransCode Therapeutics, Nutra Pharma, Curanex Pharmaceuticals, ArriVent BioPharma.

Investor discussion: Burzynski Research Institute

Members talk about Burzynski Research Institute (BZYR). Reader posts, not aibio.space reporting, and not investment advice.

Rules

Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
Say whether you hold the stock. Every post states long, short or no position.
No paid or sponsored posts. Do not post for anyone who pays or rewards you.
No buy or sell calls and no price targets.
No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open OTC:BZYR on TradingView.

Listing details

Company: Burzynski Research Institute, Inc.
Ticker: BZYR
Listing: OTC
Country or territory: United States
Business scope: Biopharma / pharmaceutical profile checked
ISIN: US1231591058
Last quote in directory: 2026-10-12
Directory source: Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction